BioSpace News Archive

Business

Rockwell Medical, Inc. Appoints Mark Strobeck, Ph.D., as President and Chief Executive Officer

Rockwell Medical , Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management, today announced that the Board of Directors has appointed Mark Strobeck , Ph.D., as President and Chief Executive Officer, effective July 1, 2022.

June 22, 2022
·
5 min read
Job Trends

Sanofi to Launch Artificial Intelligence Centre of Excellence in Toronto

Sanofi is pleased to announce the opening of an Artificial Intelligence Centre of Excellence in Toronto, joining Sanofi’s global network of existing digital hubs in Paris, Boston, New York and Barcelona.

June 22, 2022
·
4 min read
Bio NC

Mycovia Pharmaceuticals Announces Positive New Clinical Findings Evaluating VIVJOA™ (oteseconazole) Capsules in Patients with Recurrent Vulvovaginal Candidiasis (RVVC)

Mycovia Pharmaceuticals, Inc. today shared topline results from evaluating VIVJOA™ (oteseconazole) capsules in patients suffering from recurrent vulvovaginal candidiasis (RVVC).

June 22, 2022
·
6 min read
Genetown

Comera Life Sciences Announces Issuance of U.S. Patent for Proprietary Excipients in SQore Platform

Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, expanded its patent portfolio with the issuance of U.S. Patent No. 11,357,857 (the ‘857 patent).

June 22, 2022
·
6 min read
Genetown

PharmaEssentia Honored at the National Organization of Rare Disorders (NORD®) 2022 Rare Impact Awards for the Introduction of BESREMi® (ropeginterferon alfa-2b-njft) for Polycythemia Vera

PharmaEssentia Honored at the National Organization of Rare Disorders (NORD ® ) 2022 Rare Impact Awards for the Introduction of BESREMi ® (ropeginterferon alfa-2b-njft) for Polycythemia Vera.

June 22, 2022
·
14 min read
BioMidwest

Zebra’s First Healthcare-Grade Tablets Deliver Better Patient and Provider Experience

Zebra Technologies Corporation, an innovator at the front line of business with solutions and partners that deliver a performance edge, announced the ET4x-HC series, including the Android™-based ET40-HC and ET45-HC tablets, built to improve staff efficiency, care quality and the patient experience.

June 22, 2022
·
6 min read
FDA

VBI Vaccines Receives U.S. FDA Orphan Drug Designation for VBI-1901 for the Treatment of Glioblastoma

VBI Vaccines Inc. today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for VBI-1901, a bivalent gB/pp65 immunotherapeutic vaccine candidate for the treatment of glioblastoma (GBM).

June 22, 2022
·
7 min read
Business

Vibe Bio Launches To Transform Drug Development For Patients With Rare Diseases

New biotech company to use crypto to develop treatments for rare diseases.

June 22, 2022
·
4 min read
BioCapital

OpGen Announces 1,000th Patient Sample Enrolled in Clinical Trial for Unyvero Urinary Tract Infection Panel

Prospective multicenter trial for the Unyvero UTI panel recruited its 1,000th prospective patient sample.

June 22, 2022
·
5 min read
Business

Mindset Pharma and Top Psychiatric Research Hospital, CAMH, Enter Innovative Collaboration to Build Molecular Profile of MSP-1014 Compared to Psilocybin

Mindset Pharma Inc. today announced that the Company has entered into an innovative research collaboration with the Centre for Addiction and Mental Health (“CAMH”).

June 22, 2022
·
3 min read